Abstract submission
is now open for the next EACPT Congress, to be held in Geneva 28-31 August
2013. The congress includes symposia, keynote lectures and peer-reviewed oral
and poster communications.
Symposium on treating rare inborn errors of metabolism : from theory to practice
Inborn errors of metabolism represent a relatively new and rapidly
expanding class of genetic diseases. Signs and symptoms can affect all organs
and may start at any age, from infancy to old age. Tremendous advances in
laboratory techniques have led the way to the identification of hundreds of
different diseases, requiring development of very diverse new therapeutic
approaches, such as enzyme replacement or pharmacological chaperone therapies.
Inborn errors of metabolism offer not only new niches for orphan drug
developers, but also models to get a better understanding of physiological
pathways that play a role in many, more common diseases.
2013
EACPT Congress
Over 900 participants are expected to attend including health professionals, scientists, policy makers, biotechnology and pharmaceutical professionals, and others with an interest in basic and clinical pharmacology, pharmacotherapy, drug discovery and development, regulatory affairs and related areas.
Over 900 participants are expected to attend including health professionals, scientists, policy makers, biotechnology and pharmaceutical professionals, and others with an interest in basic and clinical pharmacology, pharmacotherapy, drug discovery and development, regulatory affairs and related areas.
EACPT Geneva 2013 Congress website
www.eacpt2013.org
No comments:
Post a Comment